NASDAQ:RXST

Rxsight Stock Insider Trading

Healthcare > Medical - Devices

Buy RXST

*Your capital is at risk

$6.01

-0.0700 (-1.15%)

At Close: Jul 31, 2026

RxSight Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 91.61. In total, the insiders bought 6.31M and sold 37.9K RXST shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	91.61
● Buy	6.31M shares
● Sell	37.9K shares
92% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Jul 24, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 91.61. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (92% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 27, 2026 Buy	Restricted Stock Unit A-Award	Gaines Scott Chief Customer Officer	Officer	32 218 Value: $241.0K
Feb 27, 2026 Buy	Restricted Stock Unit A-Award	Goldshleger Ilya Chief Operating Officer	C-Suite Officer	32 218 Value: $241.0K
Feb 27, 2026 Buy	Restricted Stock Unit A-Award	Weinberg Eric See Remarks	Officer	32 218 Value: $241.0K
Jan 12, 2026 Buy	Restricted Stock Unit A-Award	Wilterding Mark Chief Financial Officer	C-Suite Officer	163 528 Value: $1.65M
Jan 12, 2026 Buy	Stock Option (right to buy) A-Award	Wilterding Mark Chief Financial Officer	C-Suite Officer	258 770 Value: $2.61M
Jan 11, 2026 Buy	Common Stock J-Other	Wilterding Mark Insider	Other	0 Value: $0
Dec 18, 2025 Buy	Stock Option (right to buy)	Gaines Scott Chief Customer Officer	Officer	25 000 Value: $1.16M
Dec 18, 2025 Buy	Restricted Stock Unit	Gaines Scott Chief Customer Officer	Officer	3 750 Value: $46.2K
Dec 18, 2025 Buy	Stock Option (right to buy)	Gaines Scott Chief Customer Officer	Officer	25 000 Value: $194.5K
Dec 18, 2025 Buy	Stock Option (right to buy)	Gaines Scott Chief Customer Officer	Officer	18 285 Value: $515.8K
Dec 18, 2025 Buy	Stock Option (right to buy)	Gaines Scott Chief Customer Officer	Officer	9 999 Value: $560.6K
Dec 18, 2025 Buy	Common Stock	Gaines Scott Chief Customer Officer	Officer	0 Value: $0
Dec 18, 2025 Buy	Stock Option (right to buy)	Gaines Scott Chief Customer Officer	Officer	22 917 Value: $294.5K
Dec 18, 2025 Buy	Stock Option (right to buy)	Gaines Scott Chief Customer Officer	Officer	14 167 Value: $211.8K
Sep 25, 2025 Buy	Common Stock M-Exempt	Goldshleger Ilya See Remarks	Officer	8 349 Value: $34.5K
Sep 25, 2025 Buy	Common Stock M-Exempt	Goldshleger Ilya See Remarks	Officer	15 096 Value: $65.5K
Sep 25, 2025 Buy	Stock Option (right to buy) M-Exempt	Goldshleger Ilya See Remarks	Officer	8 349 Value: $34.5K
Sep 25, 2025 Buy	Stock Option (right to buy) M-Exempt	Goldshleger Ilya See Remarks	Officer	9 680 Value: $42.0K
Sep 25, 2025 Buy	Stock Option (right to buy) M-Exempt	Goldshleger Ilya See Remarks	Officer	9 680 Value: $42.0K
Sep 25, 2025 Buy	Stock Option (right to buy) M-Exempt	Goldshleger Ilya See Remarks	Officer	8 349 Value: $34.5K
Sep 25, 2025 Buy	Common Stock M-Exempt	Goldshleger Ilya See Remarks	Officer	15 096 Value: $65.5K
Sep 25, 2025 Buy	Common Stock M-Exempt	Goldshleger Ilya See Remarks	Officer	8 349 Value: $34.5K
Jul 31, 2025 Buy	Common Stock A-Award	Cohen Raymond W Director	Director	35 668 Value: $277.5K
Jul 31, 2025 Buy	Common Stock J-Other	Cohen Raymond W Insider	Other	0 Value: $0
Jul 31, 2025 Buy	Common Stock J-Other	Cohen Raymond W Insider	Other	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT RXSIGHT, INC.

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment dev...

Read Full Profile Here